1. Ahmed MElnour , Abozer YElderdery, Jeremy Mills, Babiker A Mohammed, Daw ElbaitAbdelaal , Abdelrahim Osman Mohamed, Kamal Eldin H Elhassan, Abdel Hady A . Abdel Wahab, Alan Cooper. BRCA 1& 2 mutation in Sudanese secondry schools girls with known breast cancer in their families. Intl J Health Sci , 2012; 6(1):63-71.

2. Elderdery AY, Mills J, Mohamed BA, Cooper AJ, Mohammed AO, Eltieb N, Old J. Molecular analysis of the beta-globin gene cluster haplotypes in a Sudanese population with sickle cell anaemia.Intl J Lab Hematol, 2012; 34(3):262-6.

3. Mohamed Abdelrahim O, Elnur Tahani, Abd Algbar R. “Role of the Sudanese higher education institutions in the peace building process”. Proceedings of the 4th International Barcelona Conference on higher Education, 2008,Vol 5. The role of higher education in peace building and reconciliation processes. Barcelona: GUNI. Available at http:/www.guni-rmies.net

4. Ahamed ME, Eltoum AAM, Altahir GO, Ahmed KM, Harbi SO, Stanslas J, Mohamed AO. Abnormal proteins in primary breast cancer tissues from 25 Sudanese patients. European Journal of Inflammation 2008, 6(3): 115-121.

5. Siddig A, Mohamed AO, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A. Estrogen receptor α gene polymorphism and the risk of breast cancer. Ann. N Y Acad Sci, 2008; 1138: 95-107.

6. Siddig A, Mohamed AO, Hammed K, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A. HER-2/neu Ile655Val polymorphism and the risk of breast cancer. Ann N Y Acad Sci 2008; 1138:84-94.

7. Mohamed AO, Malik EM. Artemisinin-based Combination Therapy in an area of Seasonal Unstable Malaria Transmission in Central Sudan, Africa in Lee O Koning editor: Progress in Malaria Research pp. 193-204, Nova Science Publishers (2007).

8. Protein sequence of 36-48; 52-65; 141-149 and 206-217 (ISOFORM 2), tissue specificity. Tissue=Mammary cancer; Ahamed M.E., Mohamed A.O., Ahmed M.E., Sirrinuch B., Surasak J.; ” Protein content study revealed high concentration of isoform 2 of beta-tropomyosin in primary breast cancer tissues from Sudanese patients.” Submitted (JUL-2006) to the Swiss-Prot. http://www.ebi.uniprot.org/ Sudan Journal of Medical Sciences 2007, 2(3):183-187.

9. Eriksson J, Reimert CM, Kabatereine NB, Kazibwe F, Ireri E, Kadzo H, Eltahir HB, Mohamed AO, Vennervald BJ, Venge P. The 434(G>C) polymorphism within the coding sequence of eisonophil cationic protein (ECP) correlates with the natural course of Schistosoma mansoni infection. International journal for Parasitology 2007, 37: 1359-1366.

10. Mohamed MI, Mohamed AO, Elghazali G, Eltom AM, Abukh BH, Mukhtar E, Elbashir MI. Diabetic retinopathy and associated risk factors in type 2 diabetes mellitus in Sudan. Sudan Medical Journal 2004, 41(2-3): 4-11 (published 2006).

11. Mohamed MI, Elbashir MI, Daoud OH, Elmahdi EMA, Mohamed AO. Significance of microalbuminuria as a marker for microangiopathy and coronary heart disease in Sudanese diabetic patients. Sudan Medical Journal 2004, 41(2-3) 20-27 (published 2006).

12. El Mahdi SA, Mohamed AO. Plasma thyroid hormones and lipids profiles in Sudanese patients with hypothyroidism. Sudan Medical Monitor 2006, 1(1): 19-21.

13. Mohamed AO, Abdel Aziz N. The use of long acting chloramphenicol in the treatment of acute bacterial meningitis in North Darfur State, Sudan 1999. Sudanese Journal of Public Health 2006, 1(2):148-149.

14. Mohammed AO, Attalla B, Bashir FM, Ahmed FE, El Hassan AM, Ibnauf G,Jiang W, Cavalli-Sforza LL, Karrar ZA, Ibrahim ME. Relationship of the sickle cell gene to the ethnic and geographic groups populating the Sudan. Community Genet.2006, 9(2):113-120.

15. Mohamed AO, Eltaib EH, Ahmed OA, Elamin SB, Malik EM. The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether- lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in an area of low transmission in central Sudan. Ann Trop Med Parasitol 2006, 99(8):1-6.

16. S. B. Elamin, G. E. Sidig, K. A. Elmardi, T. A. Mohamed, E. S. Ahmed, A. O. Mohamed and E. M. Malik. The Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Falciparum Malaria in Children in an Area of High Transmission in Southern Sudan. Sudanese Journal of Public Health (SJPH) 2006, 1(3): 197-202 .

17. Mohammed AO, Elghazali G, Mohammed HB, Elbashir MI, Xu S, Berzins K, Venge P. Human neutrophil lipocalin: a specific marker for neutrophil activation in severe Plasmodium falciparum malaria. Acta Tropica 2003, 87: 279-285.

18. Kafi SK, Mohamed AO, Musa HA. Prevalence of sexually transmitted diseases (STD) among women in a suburban Sudanese community. Upsala J Med Sci 2000; 105:249-254.

19. Mohamed AO, El Tahir SH, Mohamed HB, Ahmed SAM.Studies on Sudanese urinary stone formers. Proceedings of the 1st meeting of federation of African Societies of Biochemistry & Molecular Biology (FASBMB) 1998; 57-60.

20. Mohamed AO, Hjelm M, Hofvander Y, Ronquist G. Sickle cell disease in Sudan: Relationships between growth, haematological and biochemical variables and age. Proceedings of the 1st meeting of federation of African Societies of Biochemistry & Molecular Biology (FASBMB) 1998; 109-114.

21. Mohamed AO, Fahal AH, Venge P. Immunoglobulin and inflammatory markers profiles in mycetoma. East Afr Med J 1996 3:212.

22. Mohamed AO, Elbashir MI, Ibrahim G, Ismail M, Venge P. Neutrophil leucocyte activation in vivo in severe malaria. Trans Roy Soc Trop Med Hyg 1996; 90:277.

23. Mohamed AO. Sickle cell disease in the Sudan; clinical and biochemical aspects: Minireview based on Doctoral thesis. upsala J Med Sci 1993, 97:201-228.

24. Mohamed AO, Jansson إ, Ronquist G. Increased activity of 5’nucleotidase in serum of patients with sickle cell anaemia. Scand J Clin Lab Invest 1993; 53:701-704.

25. Mohamed AO, Hashim MS-K, Nilsson UR, Venge P. Increased in vivo activation of neutrophils and complement in sickle cell disease. Am J Trop Med Hyg 1993; 49(6):799-803.

26. Ibrahim SA, Mustafa D, Mohamed AO, Mohed MB. Homozygous haemoglobin O disease and conjugated hyperbilirubinaemia in a Sudanese family. BMJ. 1992, 304(6818):26-27.

27. Mohamed AO, Nilsson UR, Omer MIA, Ronquist G. Lack of Evidence for altered complement and immunoglobulin levels in patients with sickle cell anaemia. Scand J Clin Lab Invest 1992; 52:313-316.

28. Mohamed AO, Ronquist g, Bayoumi RA. Increased membrane activity of glyceraldehyde 3-phosphate dehydrogenase in erythrocytes of patients with homozygous sickle cell anaemia. Clin Chim Acta 1992; 209:189-195.

29. Mohamed AO, Bayoumi R, Hofvander Y, Omer MIA, Ronquist G. Sickle cell disease in Sudan: clinical findings, haematological and serum variables. Ann Trop Paediatr 1992; 12:131-136.

30. Mohamed AO, Ronquist G. Reduction in band 3 protein in red cells in sickle cell anaemia. Upsala J Med Sci 1991; 96:23-33.

Other Publications:

31. Disaster Preparedness in the Sudan: Initial Assesment of Public Health Aspects, a thesis submitted for partial fulfillment of the degree of Master of Medical Sciences, Department of Women’s and Children’s Health, Section for International Maternal and Child Health (IMCH), University of Uppsala, Sweden 2002.

32. Bakhieta Atta Allah and Abdelrahim O. Mohamed. Standard Case Management of Sickle Cell Anaemia in the Sudan. WHO/EMRO 2000 .

33. Abdelrahim O. Mohamed and Ali M. Idris. National Strategic Plan for Control of Sickle Cell Anaemia. WHO/EMRO 2000 .

Manuscripts:

34. Eltahir HB1, Dandara C2, Parker MI3, Ahmed ME4, Fedail SS5, Mohamed AO6. The role of polymorphisms in cytochrome P450, sulphotransferase and glutathione S-transferase genes in susceptibility to oesophageal cancer among the Sudanese people (Manuscript ready for submission).

35. Omar NE, GMH Satti, Mohamed AO. Correlation between the plasma level of von willebrand factor and the severity of sickle cell disease (manuscript) .

36. Mohamed AO. Evaluation of student project material and its relevance for use as reference values. A paper presented at the 5TH International Congress of the Federation of African Societies of Biochemistry and Molecular Biology (FASBMB) Abuja, Nigeria 21-24 Nov. 2006 .